Skip to main content

Animations

MJFF Publications

2981 - 2990 of 8571 Results
Title
Year
  • Year
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2025
  • 2015
  • 2022
  • 2025
  • 2025
  • Summary Details
    OPEN
    Title: The immune system in Parkinson’s disease: what we know so far
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1093/brain/awae177
    Best OA location URL:
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Transcriptomics of Human Brain Tissue in Parkinson’s Disease: a Comparison of Bulk and Single-cell RNA Sequencing
    Journal Name: Molecular Neurobiology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s12035-024-04124-5
    Best OA location URL:
    Citation Count: 2
  • Summary Details
    OPEN
    Title: A framework for translational therapy development in deep brain stimulation
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1038/s41531-024-00829-5
    Best OA location URL:
    Citation Count: 0
  • Summary Details
    OPEN
    Title: The integrated stress response in brain diseases: A double-edged sword for proteostasis and synapses
    Journal Name: Current Opinion in Neurobiology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.conb.2024.102886
    Best OA location URL:
    Citation Count: 1
  • Summary Details
    RESTRICTED
    Title: The role of genetics in the treatment of dystonia with deep brain stimulation: Systematic review and Meta-analysis
    Journal Name: Journal of the Neurological Sciences
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.jns.2024.122970
    Best OA location URL:
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: Disease-Modifying Therapies in Parkinson’s Disease
    Journal Name: Neurologic Clinics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.ncl.2024.12.009
    Best OA location URL:
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: Fanning the Flames in Anti-N-methyl-D-aspartate Receptor Encephalitis
    Journal Name: International Journal of Gynecological Pathology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1097/pgp.0000000000000186
    Best OA location URL:
    Citation Count: 0
  • Summary Details
    OPEN
    Title: A Spatiotemporal Map of the Aging Mouse Brain Reveals White Matter Tracts as Vulnerable Foci
    Journal Name: SSRN Electronic Journal
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.2139/ssrn.4260648
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Sedation and sleep safety of pimavanserin for Parkinsons’s disease psychosis: Review and exploratory analysis of clinical study data
    Journal Name: Clinical Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.prdoa.2025.100342
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Radioligands Targeting the Purinergic P2X Receptors
    Journal Name: Cells
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/cells14130984
    Citation Count: 0
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.